Literature DB >> 22246155

Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey.

Cigdem Karakukcu1, Derya Kocer, Yasemin Altuner Torun, Musa Karakukcu, Osman Yokus, Mehmet Akif Ozdemir, Turkan Patiroglu.   

Abstract

OBJECTIVE: The aim of the present study was to report the frequency of β-thalassemia trait and other hemoglobinopathies in Kayseri province, which is located in Middle Anatolia of Turkey, as part of the premarital screening program.
METHODS: The study included subjects admitted to Family Planning Center for premarital screening test between January 2009 and March 2010. Blood samples of the couples were obtained during admission to the marriage office. Complete blood counts and hemoglobin (Hb) variant analysis were performed with automatic counter and capillary electrophoresis.
RESULTS: A total of 10,261 people were screened. The prevalence of patients with the β-thalassemia trait was 1.71% (175/10261). Moreover, HbD Punjab and HbO Arab were the most common Hb variants after β-thalassemia trait with the frequencies of 0.36% and 0.09%, respectively. Only 2 HbS were detected in 15 months of screening time. In 2 couples both partners were found to be carriers of β-thalassemia trait, and both partners of 1 couple to be carrier of HbD.
CONCLUSIONS: Kayseri is not a high-risk region according to Mediterranean parts of Turkey, but the city takes migrations apart from neighbor cities, migrations from East and South provinces because of its geographic and industrial situation. For that reason detecting carrier couples with premarital screening program is an effective way of controlling thalassemia major.

Entities:  

Mesh:

Year:  2012        PMID: 22246155     DOI: 10.1097/MPH.0b013e3182370bdf

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  Premarital Screening of Beta Thalassemia Minor in north-east of Iran.

Authors:  H Hashemizadeh; R Noori
Journal:  Iran J Ped Hematol Oncol       Date:  2013-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.